Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Astellas Pharma Total Long Term Liabilities 2012-2024 | ALPMY

Astellas Pharma total long term liabilities from 2012 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Astellas Pharma total long term liabilities for the quarter ending June 30, 2024 were $4.386B, a 56.32% increase year-over-year.
  • Astellas Pharma total long term liabilities for 2024 were $4.555B, a 172.27% increase from 2023.
  • Astellas Pharma total long term liabilities for 2023 were $1.673B, a 10.43% increase from 2022.
  • Astellas Pharma total long term liabilities for 2022 were $1.515B, a 43.02% decline from 2021.
  
Astellas Pharma Annual Total Long Term Liabilities
(Millions of US $)
2024 $4,555
2023 $1,673
2022 $1,515
2021 $2,659
2020 $2,113
2019 $1,276
2018 $1,587
2017 $1,332
2016 $1,052
2015 $498
2014 $426
2013 $745
2012 $834
2011 $
2010 $
2009 $
Astellas Pharma Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $4,386
2023-06-30 $1,665
2022-06-30 $1,557
2021-06-30 $2,594
2020-06-30 $2,806
2019-06-30 $1,940
2018-06-30 $1,398
2017-06-30 $1,625
2016-09-30 $1,004
2016-06-30 $991
2016-03-31 $1,052
2015-12-31 $458
2015-09-30 $429
2015-06-30 $451
2015-03-31 $498
2014-12-31 $468
2014-09-30 $433
2014-06-30 $438
2014-03-31 $426
2013-12-31 $639
2013-09-30 $675
2013-06-30 $653
2013-03-31 $745
2012-12-31 $875
2012-09-30 $799
2012-06-30 $798
2012-03-31 $834
2011-12-31 $746
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $22.060B $11.108B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $89.015B 35.47
Takeda Pharmaceutical (TAK) Japan $47.155B 9.44
Merck (MKGAF) Germany $23.651B 25.81
Summit Therapeutics (SMMT) United States $17.795B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.649B 0.00
United Therapeutics (UTHR) United States $15.242B 15.74
Shionogi (SGIOY) Japan $13.107B 12.56
Neurocrine Biosciences (NBIX) United States $12.102B 36.21
Catalent (CTLT) United States $10.946B 0.00
Orion OYJ (ORINY) Finland $7.423B 30.23
Revolution Medicines (RVMD) United States $7.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.766B 7.18
Ionis Pharmaceuticals (IONS) United States $6.194B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.063B 0.00
Corcept Therapeutics (CORT) United States $4.417B 37.41
Crinetics Pharmaceuticals (CRNX) United States $4.223B 0.00
Dyne Therapeutics (DYN) United States $3.448B 0.00
PTC Therapeutics (PTCT) United States $2.729B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.696B 15.55
Arrowhead Pharmaceuticals (ARWR) United States $2.583B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.425B 19.27
Soleno Therapeutics (SLNO) United States $2.082B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.942B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.780B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.647B 0.00
Xencor (XNCR) United States $1.625B 0.00
Harrow (HROW) United States $1.608B 0.00
Cassava Sciences (SAVA) United States $1.455B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.436B 0.00
Ocular Therapeutix (OCUL) United States $1.411B 0.00
Ardelyx (ARDX) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.347B 6.18
Avadel Pharmaceuticals (AVDL) Ireland $1.314B 0.00
Evotec AG (EVO) Germany $1.290B 0.00
Collegium Pharmaceutical (COLL) United States $1.249B 7.17
Calliditas Therapeutics AB (CALT) Sweden $1.200B 0.00
Enliven Therapeutics (ELVN) United States $1.028B 0.00
Relay Therapeutics (RLAY) United States $1.015B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.013B 0.00
Bioventus (BVS) United States $0.947B 30.76
4D Molecular Therapeutics (FDMT) United States $0.874B 0.00
Cronos Group (CRON) Canada $0.868B 0.00
USANA Health Sciences (USNA) United States $0.759B 13.92
Savara (SVRA) United States $0.731B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.722B 45.20
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.676B 6.40
Exscientia (EXAI) United Kingdom $0.631B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.569B 6.81
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
OmniAb (OABI) United States $0.545B 0.00
Tourmaline Bio (TRML) United States $0.538B 0.00
Eliem Therapeutics (ELYM) United States $0.535B 0.00
Foghorn Therapeutics (FHTX) United States $0.529B 0.00
Altimmune (ALT) United States $0.528B 0.00
Verve Therapeutics (VERV) United States $0.466B 0.00
Sage Therapeutics (SAGE) United States $0.463B 0.00
KalVista Pharmaceuticals (KALV) United States $0.462B 0.00
Aquestive Therapeutics (AQST) United States $0.451B 0.00
Larimar Therapeutics (LRMR) United States $0.437B 0.00
Xeris Biopharma Holdings (XERS) United States $0.432B 0.00
Elite Pharmaceuticals (ELTP) United States $0.414B 38.75
Zevra Therapeutics (ZVRA) United States $0.412B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Aldeyra Therapeutics (ALDX) United States $0.349B 0.00
Lyell Immunopharma (LYEL) United States $0.346B 0.00
Korro Bio (KRRO) United States $0.342B 0.00
Esperion Therapeutics (ESPR) United States $0.341B 0.00
Lexeo Therapeutics (LXEO) United States $0.317B 0.00
Heron Therapeutics (HRTX) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.284B 0.00
Avita Medical (RCEL) United States $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.251B 17.14
Enanta Pharmaceuticals (ENTA) United States $0.241B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.240B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Nanobiotix S.A (NBTX) France $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.232B 0.00
Pyxis Oncology (PYXS) United States $0.216B 0.00
CytoDyn (CYDY) United States $0.199B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.196B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
Century Therapeutics (IPSC) United States $0.140B 0.00
Prelude Therapeutics (PRLD) United States $0.134B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Fractyl Health (GUTS) United States $0.128B 0.00
Assertio Holdings (ASRT) United States $0.124B 21.67
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Journey Medical (DERM) United States $0.106B 0.00
Regulus Therapeutics (RGLS) United States $0.106B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
CASI Pharmaceuticals (CASI) China $0.105B 0.00
Metagenomi (MGX) United States $0.100B 0.00
Citius Pharmaceuticals (CTXR) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Vivani Medical (VANI) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Inotiv (NOTV) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.047B 0.00
FibroGen (FGEN) United States $0.042B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Protara Therapeutics (TARA) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Tempest Therapeutics (TPST) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
BioVie (BIVI) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Indaptus Therapeutics (INDP) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.48
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.56